Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
depression
life sciences
national blog main
national top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medicine
national
new york blog main
new york top stories
postpartum depression
raleigh-durham blog main
raleigh-durham top stories
sage therapeutics
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
study
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acc
acquisition
activist investor
aducanumab
alzheimer's failure
american college of cardiology
amyloid
andreas grauer
What
depression
4
×
medical
drug
postpartum
sage
trial
week
adu
alto
announced
approval
approved
beats
bids
bio
biogen
brexanalone
cancer
centers
cerebral
clinical
complicated
cut
decentralized
dire
earnest
embarked
event
fda
forced
forefront
genetic
good
group
guesswork
guide
health
heart
help
helps
Language
unset
Current search:
depression
×
biotech
×
@techcrunch.com
2 years ago
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?
